Angene Chemical
Draw
|
Currency :
Home Products

AG00E8QL

57-64-7 | Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1)

Chemical structure of Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1), CAS 57-64-7
AG00E8QL
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 57-64-7
Catalog Number AG00E8QL(AGN-PC-0SO4ZF)
Chemical Name Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl N-methylcarbamate (1:1)
EC Number 200-343-8
IUPAC Name [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid
InChI InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1
InChI Key HZOTZTANVBDFOF-PBCQUBLHSA-N
MDL Number MFCD00135659
Molecular Formula C22H27N3O5
Molecular Weight 413.4669
NSC Number 757275
RTECS Number TJ2450000
SMILES OC(=O)c1ccccc1O.CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C1N2C)C
UNII 2046ZRO9VU
Synonyms
Antilirium, eserine salicylate, physostigmine salicylate, pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3as-cis)-, mono(2-hydroxybenzoate), Physostigmine salicylate, 57-64-7, UNII-2046ZRO9VU, MLS000028388, 2046ZRO9VU, CHEBI:48883, SMR000058606, SR-01000075341, Antilirium (TN), [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid, C15H21N3O2.C7H6O3, Physostigmine salicylate [USP:JAN], Eserine monosalicylate, AC1LCWEA, Spectrum_000223, Opera_ID_194, Physostigmine salicylate salt, SCHEMBL41555, KBioSS_000703, physostigmine; salicyclic acid, DivK1c_000339, SPECTRUM1500486, CHEMBL338975, HMS501A21, KBio1_000339, KBio2_000703, KBio2_003271, KBio2_005839, HZOTZTANVBDFOF-PBCQUBLHSA-N, NINDS_000339, HMS1920H12, HMS2091P16, HMS2235G19, Pharmakon1600-01500486, BCP25378, Physostigmine salicylate (JAN/USP), 6290AF, CCG-39918, NSC757275, NSC-757275, SDCCGMLS-0002925.P003, IDI1_000339, NCGC00024464-02, Eserine salicylate salt, >=97.0% (N), D02418, SR-01000075341-3, SR-01000075341-5, SR-01000075341-7, Physostigmine salicylate, European Pharmacopoeia (EP) Reference Standard, Physostigmine salicylate, United States Pharmacopeia (USP) Reference Standard, (3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate 2-hydroxybenzoate, (3aS,8aR)-1,3a,8-trimethyl-5-(methylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indolium salicylate, [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate; 2-hydroxybenzoic acid, Antilirium, Eserine salicylate, Isopto Eserine, Physostol salicylate, Isopto P-ES, Physostigmine monosalicylate, RCRA waste no. P188, CCRIS 3405, PHYSOSTIGMINESALICYLATE, Physostigmine, salicylate (1:1), Physostigmine salicylate(1:1), AR-44, Physostigmine salicylate [JAN], EINECS 200-343-8, TL-1380, CID657348, Physostigmine salicylate [USAN:JAN], C15-H21-N3-O2.C7-H6-O3, Salicylic acid, compd. with physostigmine (1:1), C026718, Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate), Benzoic acid, 2-hydroxy-, compd with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate ester (1:1), Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl methylcarbamate (1:1), Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl N-methylcarbamate (1:1), Benzoic acid, 2-hydroxy-, compd. with (3aS,8aR)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1), Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl methylcarbamate ester (1:1), Benzoic acid, 2-hydroxy-, compd. with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate ester (1:1), Benzoic acid, 2-hydroxy-, compound with (3aS-cis)-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indol-5-yl methylcarbamate (1:1),

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited